Loading stock data…
CNC
$53.34-0.35 (-0.65%)
Market ClosedLast close May 1
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Centene Corporation in the Healthcare sector is trading at $53.34. The stock is currently 17% below its 52-week high of $64.15, remaining 45.2% above its 200-day moving average. Technical signals show overbought RSI of 90 and bullish MACD crossover, explaining why CNC maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Overbought levels (RSI 90) — risk of consolidation or pullback
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$53.34
Potential Upside
5%
Whystock Fair Value$56.01
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus17 analysts
Buy
Mean target$52.59-1.4%
Range$38.00 – $70.00
Fundamentals
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$19.77B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
Defensive asset. Lower volatility than the S&P 500.
0.59
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
10.29%
Volume
Today's trading volume
5.89M
Recent News
UnitedHealth Pops 14.5% After Q1 Beat: Still a Buy or Too Late Now?
UNH surges 14.5% after a Q1 earnings beat and raised 2026 outlook, but membership declines, DOJ probes and valuation concerns could cap the rally.
The Medicaid Pain Is Ending. Buy Elevance Health and These 2 Stocks.
BofA Securities upgrades Elevance Health and gives a rare double upgrade to Centene and Molina Healthcare.
Centene Corporation (CNC): David Einhorn Is Bullish on This Managed Care Firm
We just covered 15 Under-the-Radar Picks from David Einhorn That Are Quietly Dominating 2026 and Centene Corporation (NYSE:CNC) ranks 1st on this list. Centene Corporation (NYSE:CNC) recently posted Q1 2026 results that significantly cleared the high bar set by institutional expectations. The company delivered an Adjusted EPS of $3.37 on $49.94 billion in revenue, far exceeding […]
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
Spotify upgraded, Alibaba initiated: Wall Street's top analyst calls
Analysts upgrade Elevance, Centene shares as Medicaid margins expected to recover
Investing.com -- Bank of America upgraded Elevance Health and gave Centene Corporation a double upgrade on Wednesday amid growing confidence that Medicaid margins are nearing a trough and are set to recover over the next several years.